26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.
作者信息
Thompson P D, Klocke F J, Levine B D, Van Camp S P
出版信息
J Am Coll Cardiol. 1994 Oct;24(4):888-92. doi: 10.1016/0735-1097(94)90846-x.